Kyntra Bio to Report Second Quarter 2026 Financial Results

Go back to Kyntra Bio to Report Second Quarter 2026 Financial Results
(NASDAQ: KYNB) Delayed: 3.96 -0.35 (8.12%)
Previous Close $4.31    52 Week High $ 
Open $4.46    52 Week Low $ 
Day High $4.87    P/E N/A 
Day Low $3.96    EPS $ 
Volume 17,625